Javascript must be enabled to continue!
The Pathophysiology, Presentation and Management of Ischaemic Colitis: A Systematic Review
View through CrossRef
AbstractThere are currently no guidelines on the long‐term management of patients after an episode of acute ischaemic colitis. Our aim was to review the literature on the pattern of presentation and the pathophysiology of this condition and to understand the current status of the acute and long‐term management of ischaemic colitis. Furthermore, we aim to provide recommendations for the clinicians in regard to the acute and long‐term management of ischaemic colitis. A review of the English literature over the last 15 years was performed using Embase and Medline. Search terms were ischaemic OR ischemic, colitis OR colon. Two reviewers screened the papers against pre‐determined eligibility criteria. A senior consultant surgeon performed a final overview. Three hundred sixty‐eight papers were identified on the initial search; 318 were irrelevant and 17 were conference abstracts; both were excluded. Thirty‐three full articles were assessed for suitability; nine were further excluded. Twenty‐four articles were included in the final analysis and cross‐referenced against those listed in the systematic reviews. There is a large clinical heterogeneity in inclusion criteria (histological, radiological, endoscopic, surgical specimen). Twelve out of 24 articles included patients only based on histological diagnosis. The definition of right and left (or nonright) ischaemic colitis was variable based on whether hepatic or splenic flexure was used as the cut‐off point. Five retrospective case series highlighted that patients with isolated right‐sided ischaemic colitis had a worse prognosis than those with left‐sided colitis (higher mortality, need for surgery, length of hospital stay). The overall recurrence was 9%. There is a need for a higher‐level evidence to guide clinicians on the long‐term management of patients following an episode of acute colonic ischaemia. Further evidence is required to determine whether right colonic ischaemia should be managed differently from left.
Title: The Pathophysiology, Presentation and Management of Ischaemic Colitis: A Systematic Review
Description:
AbstractThere are currently no guidelines on the long‐term management of patients after an episode of acute ischaemic colitis.
Our aim was to review the literature on the pattern of presentation and the pathophysiology of this condition and to understand the current status of the acute and long‐term management of ischaemic colitis.
Furthermore, we aim to provide recommendations for the clinicians in regard to the acute and long‐term management of ischaemic colitis.
A review of the English literature over the last 15 years was performed using Embase and Medline.
Search terms were ischaemic OR ischemic, colitis OR colon.
Two reviewers screened the papers against pre‐determined eligibility criteria.
A senior consultant surgeon performed a final overview.
Three hundred sixty‐eight papers were identified on the initial search; 318 were irrelevant and 17 were conference abstracts; both were excluded.
Thirty‐three full articles were assessed for suitability; nine were further excluded.
Twenty‐four articles were included in the final analysis and cross‐referenced against those listed in the systematic reviews.
There is a large clinical heterogeneity in inclusion criteria (histological, radiological, endoscopic, surgical specimen).
Twelve out of 24 articles included patients only based on histological diagnosis.
The definition of right and left (or nonright) ischaemic colitis was variable based on whether hepatic or splenic flexure was used as the cut‐off point.
Five retrospective case series highlighted that patients with isolated right‐sided ischaemic colitis had a worse prognosis than those with left‐sided colitis (higher mortality, need for surgery, length of hospital stay).
The overall recurrence was 9%.
There is a need for a higher‐level evidence to guide clinicians on the long‐term management of patients following an episode of acute colonic ischaemia.
Further evidence is required to determine whether right colonic ischaemia should be managed differently from left.
Related Results
Cometary Physics Laboratory: spectrophotometric experiments
Cometary Physics Laboratory: spectrophotometric experiments
<p><strong><span dir="ltr" role="presentation">1. Introduction</span></strong&...
Ischaemic colitis - review
Ischaemic colitis - review
Colonic ischaemia, commonly referred to as ischaemic colitis, is the most common type of intestinal ischaemia. The term "ischaemic colitis" was used by Marston (1966) with three ty...
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical activi...
P0100 Role of Ethyl Pyruvate on Large Intestinal Inflammatory and Oxidative Markers in TNBS-Induced Colitis
P0100 Role of Ethyl Pyruvate on Large Intestinal Inflammatory and Oxidative Markers in TNBS-Induced Colitis
Abstract
Background
Ethyl pyruvate (EP), with anti-inflammatory and antioxidant effects, has shown therapeutic potential ...
Role of Vitamin B17 against Colitis Bearing Female Mice Induced Variations in Some Blood Parameters
Role of Vitamin B17 against Colitis Bearing Female Mice Induced Variations in Some Blood Parameters
Colorectal cancer is also the third most common cause of cancer-related death, and in the US, it ranks as the third most prevalent kind of cancer. The cells that produce mucus to l...
Mycophenolate Mofetil (MMF)-Induced Colitis
Mycophenolate Mofetil (MMF)-Induced Colitis
Abstract
Introduction
MMF is an immunosuppressive drug frequently used for graft-versus-host disease (GVHD) prophylaxis and management. MMF-induced co...
CD8+ Lymphocyte Infiltration is a Specific Feature of Colitis Induced By Immune Checkpoint Inhibitors
CD8+ Lymphocyte Infiltration is a Specific Feature of Colitis Induced By Immune Checkpoint Inhibitors
Abstract
Background
Immune checkpoint inhibitors (ICPIs) have revolutionized cancer therapy, although immune-related adverse events (irAEs) remain a severe issue. The clin...
P0193 Oral administration of Sophora Flavescens-derived exosomes-like nanovesicles carrying CX5461 ameliorates DSS-induced colitis in mice
P0193 Oral administration of Sophora Flavescens-derived exosomes-like nanovesicles carrying CX5461 ameliorates DSS-induced colitis in mice
Abstract
Background
Ulcerative colitis (UC) belongs inflammatory disease with chronic and relapsing characterizations and increa...

